New Study Highlights Role of Gut Bacteria in Boosting Immune Defense for HIV Patients

A recent study from Israel and Ethiopia, published on Thursday, reveals how gut bacteria can enhance immune defenses in individuals with early-stage HIV. This pioneering research was conducted by Prof. Eran Elinav from the Weizmann Institute of Science and Prof. Hila Elinav, director of the Hadassah AIDS Center in Jerusalem. They suggest that the gut microbiome functions as an active organ within the body’s immune system.

The findings were shared in the scientific journal Nature Microbiology, despite facing significant challenges during the research. Remarkably, one of the authors had to flee Ethiopia due to civil unrest while collecting data, and the Weizmann lab experienced damage from a missile attack in June.

The study opens doors for new medical therapies aimed at enhancing the immune systems of people living with HIV by targeting the body’s bacteria. “Our research strongly supports the idea that the microbiome and immune system influence each other,” Eran stated. “It acts like an immune organ—both shaping and responding to immunity.”

Understanding HIV’s Impact on the Immune System

HIV attacks and weakens the immune system, with AIDS being the most severe form of the infection. The virus primarily targets white blood cells, heightening the risk of other diseases like tuberculosis and some cancers. It spreads through infected bodily fluids, typically during unprotected sexual contact, sharing needles, or from mother to child.

Fortunately, with appropriate treatment, not all individuals with HIV will progress to AIDS. Currently, there are approximately 9,064 HIV-positive individuals in Israel and about 600,000 in Ethiopia. A staggering 40 million people worldwide are living with HIV, according to recent WHO data.

Investigating the Microbiome

The gut microbiome encompasses a vast community of microorganisms residing in the intestines. These microorganisms help the immune system differentiate between harmless substances and harmful pathogens. Disruptions in this balance can lead to chronic inflammation and, subsequently, a weakened immune response.

For the study, researchers examined the gut microbiomes of around 70 HIV-positive individuals in Israel and a comparable number in Ethiopia, collecting samples at various stages of the infection. Dr. Jemal Ali Mahdi, an important member of the team, initially joined as a visiting student while pursuing a PhD and played a crucial role in sample collection in Ethiopia. However, he was forced to flee to the U.S. when civil war erupted. Despite the danger, he later returned to help complete the study.

The study compared the microbiomes of participants with those of uninfected individuals from similar geographical areas. All HIV-positive participants received standard antiviral treatments, although the medications in Ethiopia were generally less advanced than those in Israel. Researchers also measured CD4 T cell levels—essential immune cells that help fend off infections. In HIV patients, the virus slowly diminishes these cells, leading to an increased risk of serious health issues if untreated.

Much of the damage occurs in the gut lining, where HIV often remains hidden. “The gut serves as a reservoir for HIV, with T cells in its lining still damaged while the rest of the body’s immune system may recover,” Hila explained. The microbiomes of HIV-positive individuals were found to differ significantly from the uninfected group, with some microbial changes observed across both Ethiopian and Israeli participants, hinting at universal biological patterns.

However, others appeared to be specific to one region, likely due to local diets and lifestyle influences. “We believe the virus isn’t directly damaging the bacteria,” Eran noted, adding that HIV primarily influences the immune system, which normally produces natural antibiotic substances.

In further experiments, the team transferred gut microbes from HIV patients and uninfected volunteers into mice lacking any microbiome. The changes in the immune response in these mice could not be attributed to HIV, as they are innately resistant to the virus. Surprisingly, gut microbes from HIV-positive individuals led to increased CD4 T cell levels in the mice’s intestines, more so than those from uninfected donors, underscoring the microbiome’s significant role in immune function during HIV infection.

However, in participants who had progressed to severe immune deficiency and AIDS, their microbiomes failed to strengthen the immune system. Mice that received bacteria from these AIDS patients exhibited low CD4 levels, showing that microbial support was lacking.

Path Forward for Treatment

The researchers suggest future HIV treatments may involve manipulating the microbiome through balanced diets, probiotics, or bacteriophages. “There’s still a lot to uncover about the specific microbes and molecules involved,” Hila said, indicating the potential for microbiome modification to enhance immunity and reduce the risk of life-threatening infections for HIV patients.

Additionally, given Hila’s volunteer experience in clinics in Ethiopia’s Tigray region—a place challenged by poverty and conflict—she underscored the importance of this approach, particularly in areas lacking access to advanced antiviral therapies or where existing treatments fail to sufficiently restore immune function.